March 6, 2017 / 11:17 AM / 6 months ago

BRIEF-Novan provides update on SB204 development program

March 6 (Reuters) - Novan Inc

* Novan provides update on SB204 development program

* Novan Inc - Intends to proceed with SB204 development program

* Novan Inc- Meeting could lead to a new drug application, or NDA, submission targeted in Q1 of 2018

* Novan Inc - Continues to believe that company's cash on hand is sufficient to fund operations at least through end of 2017

* Novan - Intends to pursue pre-submission meeting with FDA, to discuss entirety of SB204 development program in Q3 of 2017

* Novan Inc - Anticipates that additional funding will be required to support SB204 through FDA process, as well as to fund operations beyond 2017 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below